{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:50:57Z","timestamp":1787669457522,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.labinv.2025.104179","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T11:03:29Z","timestamp":1745060609000},"page":"104179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["SATB2 Loss Is a Sensitive Biomarker for Dysplasia in Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"105","author":[{"given":"Madhurya","family":"Ramineni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ettel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4858-758X","authenticated-orcid":false,"given":"Yansheng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-0632","authenticated-orcid":false,"given":"Xiaoyan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.labinv.2025.104179_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/JIR.S65979","article-title":"Inflammatory bowel disease: clinical aspects and treatments","volume":"7","author":"Fakhoury","year":"2014","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.labinv.2025.104179_bib2","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/ecco-jcc\/jjab102","article-title":"Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines","volume":"15","author":"Porter","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.labinv.2025.104179_bib3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications","volume":"14","author":"Riddell","year":"1983","journal-title":"Hum Pathol"},{"key":"10.1016\/j.labinv.2025.104179_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.giec.2019.02.008","article-title":"Management of inflammatory bowel disease-associated dysplasia in the modern era","volume":"29","author":"Shah","year":"2019","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"10.1016\/j.labinv.2025.104179_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal cancer in inflammatory bowel disease: mechanisms and management","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.labinv.2025.104179_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/gastro\/gov022","article-title":"Overexpression of p53 predicts colorectal neoplasia risk in patients with inflammatory bowel disease and mucosa changes indefinite for dysplasia","volume":"3","author":"Horvath","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.labinv.2025.104179_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ecco-jcc\/jjz135","article-title":"Clinicopathological and molecular characterisation of Crohn\u2019s disease-associated small bowel adenocarcinomas","volume":"14","author":"Liao","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.labinv.2025.104179_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100566","article-title":"Clinicopathologic and molecular characterization of inflammatory bowel disease-associated neuroendocrine carcinomas and mixed neuroendocrine-non-neuroendocrine neoplasms","volume":"37","author":"Liao","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2025.104179_bib9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00428-020-02998-z","article-title":"Interobserver agreement and the impact of mentorship on the diagnosis of inflammatory bowel disease-associated dysplasia among subspecialist gastrointestinal pathologists","volume":"478","author":"Alpert","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.labinv.2025.104179_bib10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/his.14298","article-title":"Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia","volume":"78","author":"Lee","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.labinv.2025.104179_bib11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.path.2023.05.006","article-title":"Characteristics, reporting, and potential clinical significance of nonconventional dysplasia in inflammatory bowel disease","volume":"16","author":"Choi","year":"2023","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.labinv.2025.104179_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/PAP.0000000000000316","article-title":"The significance of flat\/invisible dysplasia and nonconventional dysplastic subtypes in inflammatory bowel disease: a review of their morphologic, clinicopathologic, and molecular characteristics","volume":"29","author":"Choi","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.labinv.2025.104179_bib13","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41379-019-0419-1","article-title":"Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal carcinoma: a multicenter clinicopathologic study","volume":"33","author":"Choi","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2025.104179_bib14","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3390\/ijms18061284","article-title":"p53 expression as a diagnostic biomarker in ulcerative colitis-associated cancer","volume":"18","author":"Kobayashi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.labinv.2025.104179_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.gendis.2020.10.003","article-title":"SATB2: a versatile transcriptional regulator of craniofacial and skeleton development, neurogenesis and tumorigenesis, and its applications in regenerative medicine","volume":"9","author":"Huang","year":"2022","journal-title":"Genes Dis"},{"key":"10.1016\/j.labinv.2025.104179_bib16","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/ajmg.a.36769","article-title":"Intragenic duplication\u2014a novel causative mechanism for SATB2-associated syndrome","volume":"164A","author":"Lied\u00e9n","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.labinv.2025.104179_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2021.09.004","article-title":"SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling","volume":"29","author":"Gu","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.labinv.2025.104179_bib18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ajcp\/aqaa118","article-title":"SATB2 in neoplasms of lung, pancreatobiliary, and gastrointestinal origins","volume":"155","author":"De Michele","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.labinv.2025.104179_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100295","article-title":"Clinicopathologic and molecular characterization of anorectal neuroendocrine carcinomas reveals human papillomavirus, p53, and c-Myc as alternative mechanisms of carcinogenesis","volume":"36","author":"Cox","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2025.104179_bib20","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.5858\/arpa.2016-0243-RS","article-title":"SATB2 as an immunohistochemical marker for colorectal adenocarcinoma: a concise review of benefits and pitfalls","volume":"141","author":"Berg","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.labinv.2025.104179_bib21","article-title":"Whole genome methylation array reveals the down-regulation of IGFBP6 and SATB2 by HIV-1","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.labinv.2025.104179_bib22","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/PAS.0000000000001330","article-title":"Loss of SATB2 expression is a biomarker of inflammatory bowel disease-associated colorectal dysplasia and adenocarcinoma","volume":"43","author":"Ma","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2025.104179_bib23","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41379-018-0198-0","article-title":"Colitis-associated colorectal adenocarcinomas are frequently associated with non-intestinal mucin profiles and loss of SATB2 expression","volume":"32","author":"Iwaya","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2025.104179_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jclinpath-2019-206247","article-title":"Histological and molecular diversity and heterogeneity of precancerous lesions associated with inflammatory bowel diseases","volume":"73","author":"Gui","year":"2020","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.labinv.2025.104179_bib25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/PAS.0000000000001900","article-title":"Association between loss of SATB2 expression in inflammatory bowel disease indefinite for dysplasia and a diagnosis of definitive dysplasia on follow-up","volume":"46","author":"Cretara","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2025.104179_bib26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ecco-jcc\/jjab120","article-title":"Hypermucinous, goblet cell-deficient and crypt cell dysplasias in inflammatory bowel disease are often associated with flat\/invisible endoscopic appearance and advanced neoplasia on follow-up","volume":"16","author":"Choi","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.labinv.2025.104179_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0016-5085(94)90161-9","article-title":"Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis","volume":"107","author":"Brentnall","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.labinv.2025.104179_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/modpathol.2013.133","article-title":"Diagnostic utility of TP53 and cytokeratin 7 immunohistochemistry in idiopathic inflammatory bowel disease-associated neoplasia","volume":"27","author":"Xie","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2025.104179_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22685-0","article-title":"Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressiveness in colorectal cancer","volume":"12","author":"Hrudka","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.labinv.2025.104179_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/0284186X.2019.1691258","article-title":"Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study","volume":"59","author":"Mezheyeuski","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.labinv.2025.104179_bib31","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/00000478-200608000-00014","article-title":"Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease","volume":"30","author":"Levi","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2025.104179_bib32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.pas.0000213268.30468.b4","article-title":"AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett\u2019s esophagus, ulcerative colitis, and Crohn\u2019s disease","volume":"30","author":"Dorer","year":"2006","journal-title":"Am J Surg Pathol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T14:47:46Z","timestamp":1755614866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683725000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0023683725000893"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104179","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SATB2 Loss Is a Sensitive Biomarker for Dysplasia in Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104179"}}